Clinical trialNCT05686239CompletedPhase 2Interventional

A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS)

SponsorRecognify Life SciencesEnrollment242Cognitive ImpairmentCognitive Impairment Associated With Schizophrenia (CIAS)Schizophrenia

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Gary Walker, PhD
Recognify Life Sciences
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

36 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Bulgaria

Recognify Research Site
Burgas, Bulgaria
Recognify Research Site
Kardzhali, Bulgaria
Recognify Research Site
Pleven, Bulgaria
Recognify Research Site
Plovdiv, Bulgaria
Recognify Research Site
Sofia, Bulgaria
Recognify Research Site (a)
Varna, Bulgaria
Recognify Research Site (b)
Varna, Bulgaria

Czechia

Recognify Research Site
Pilsen, Czechia
Recognify Research Site (a)
Prague, Czechia
Recognify Research Site (b)
Prague, Czechia

Poland

Recognify Research Site
Gdansk, Poland
Recognify Research Site
Gorlice, Poland
Recognify Research Site
Kielce, Poland
Recognify Research Site
Lodz, Poland
Recognify Research Site
Lublin, Poland
Recognify Research Site
Poznan, Poland

United States

Recognify Research Site
Culver City, California, United States
Collaborative Neuroscience Research
Garden Grove, California, United States
Recognify Research Site
Lafayette, California, United States
Recognify Research Site
Oceanside, California, United States
Recognify Research Site
Orange, California, United States
Recognify Research Site
Torrance, California, United States
Recognify Research Site
Hialeah, Florida, United States
Recognify Research Site
Miami, Florida, United States
Recognify Research Site
Miami Lakes, Florida, United States
Recognify Research Site
Atlanta, Georgia, United States
Recognify Research Site
Augusta, Georgia, United States
Recognify Research Site
Gaithersburg, Maryland, United States
Recognify Research Site
Berlin, New Jersey, United States
Recognify Research Site
Brooklyn, New York, United States
Recognify Research Site
Chapel Hill, North Carolina, United States
Recognify Research Site
Cincinnati, Ohio, United States
Recognify Research Site
Cleveland, Ohio, United States
Recognify Research Site
Dallas, Texas, United States
Recognify Research Site
Houston, Texas, United States
Recognify Research Site
Everett, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 8 Dec 2022
Primary completion: 9 Apr 2025
Completion: 9 Apr 2025
Last update posted: 30 Jul 2025
Registered enrollment: 242
Registry id: NCT05686239

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.